CN108403756A - A kind of pet anti parasitic compound preparation - Google Patents

A kind of pet anti parasitic compound preparation Download PDF

Info

Publication number
CN108403756A
CN108403756A CN201810568158.7A CN201810568158A CN108403756A CN 108403756 A CN108403756 A CN 108403756A CN 201810568158 A CN201810568158 A CN 201810568158A CN 108403756 A CN108403756 A CN 108403756A
Authority
CN
China
Prior art keywords
parts
taken
takes
mass ratio
pet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201810568158.7A
Other languages
Chinese (zh)
Inventor
陈琪峰
陈炎
李莉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810568158.7A priority Critical patent/CN108403756A/en
Publication of CN108403756A publication Critical patent/CN108403756A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • A61P33/12Schistosomicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of pet anti parasitic compound preparations, belong to veterinary drug preparation preparing technical field.The present invention is using ganoderma lipsiense as raw material, the extract with β carbonic anhydrase inhibitory activity is made, the enzymatic activity can effectively be inhibited, there is extensive killing effect to pet endoparasite, and on pet without influence, coordinate zinc fingers possessed by the heat shock protein in Escherichia coli DnaJ protein liquids, it can be with β carbonic anhydrase competitive bindings Zn2+Achieve the effect that Reverse transcriptase, improve the killing effect to parasite, a variety of alkaloids such as matrine, oxymatrine, the Sophoridine contained in cooperation shrubby sophora extract can be by the nervous system of destruction polypide, cause polypide Antifeedant Effects, play expelling parasite insecticidal effect, reach notable expelling parasite insecticidal effect, and is not likely to produce drug resistance.The present invention solve it is single for the current antiparasitic formulations product structure of animal in the market, to generate drug resistance, and to the poor problem of the control effect of parasite.

Description

A kind of pet anti parasitic compound preparation
Technical field
The invention belongs to veterinary drug preparation preparing technical field, more particularly to a kind of pet anti parasitic compound preparation.
Background technology
With the development of the social economy, people’s lives level is higher and higher, pet industry has also obtained unprecedented development, with It pet and people’s lives is more and more closer, the prevention of pet parasitic disease is also increasingly valued by people.For a long time with Come, anti parasitic class chemicals are almost relied on to the control of animal parasitosis.These drugs shortly after use, Arthropod is just almost bar none to which create different degrees of drug resistance, and that there is also toxicity is big, long-term for chemicals The disadvantages such as residual in livestock products and environment.Animal parasitosis is the main original for causing domestic and international animal husbandry huge economic losses One of because.Currently, domestic ectoparasite disease mainly or relies on medical treatment, wherein chemicals are still leading at present anti- Control means.In recent years, due to a variety of different type parasite mixing senses such as nematode, tapeworm, fluke and various vermins Dye increases, and causes the therapeutic effect of folk prescription anti-parasite medicine undesirable.Ivermectin is semi-synthetic macrolides wide spectrum Antiparasitic agent kills effect to internal epizoa especially nematode and vermin with good, but to tapeworm, suction Worm and protozoan are invalid;Praziquantel is pyrazinoisoquinoline compound, which has special efficacy to snail fever, while also to tapeworm Adult, larva it is effective, but praziquantel is invalid to nematode and vermin.Therefore, as can working out rational preparation work Anti-parasitic compound preparation is made in drug by skill, and the pest-resistant spectrum of the two will be made to form perfect complementation, formed to nematode, tapeworm, suction The effective anti-parasitic compound preparation of a variety of different type parasitic infections such as worm and various vermins.However, China's veterinary drug clinic does not have ripe anti-parasitic compound preparation also, though developed countries have many compound anti-parasitic systems Agent, such as ivermectin+Pyrantel compound preparations of Merial companies, praziquantel+Pyrantel+Fei Bantuo compounds of Bayer companies Preparation, Mile companies praziquantel+Pyrantel compound preparation etc., but do not have ideal anti-parasitic compound preparation yet so far Listing.
Invention content
The technical problems to be solved by the invention:For the current antiparasitic formulations product structure list of animal in the market One, to generate drug resistance, and to the poor problem of the control effect of parasite, provide a kind of pet anti parasitic compound preparation.
In order to solve the above technical problems, the present invention is using technical solution as described below:
A kind of pet anti parasitic compound preparation includes following component according to the mass fraction:6 ~ 15 parts of essence, 4 ~ 10 portions of sucrose, 5 ~ 10 parts of auxiliary agents, 20 ~ 40 parts of water, which is characterized in that further include 20 ~ 30 parts of shrubby sophora extracts, 30 ~ 50 parts of compound enzyme inhibitors;
The preparation method of the shrubby sophora extract:It takes kuh-seng to dry, pulverize sieving, takes sieving particle in mass ratio 1:4 ~ 6 are added Methanol impregnates 2 ~ 3h, and in 50 ~ 60 DEG C of ultrasonic wave extractions, filtering takes filtrate, rotary evaporation, be concentrated under reduced pressure into original volume 20 ~ 30%, concentrate is obtained, concentrate in mass ratio 1 is taken:3 ~ 4 are added acetic acid solution mixing, stir, and filtering takes filtrate, is concentrated under reduced pressure, Medicinal extract is obtained, it is dry, obtain shrubby sophora extract;
The preparation method of the compound enzyme inhibitor, includes the following steps:
(1)Ganoderma lipsiense cleaning, drying are taken, are pulverized and sieved, sieving particle in mass ratio 1 is taken:2 ~ 3 are added water, obtain ganoderma lipsiense 0.3% cellulase of pectase and ganoderma lipsiense liquid quality of ganoderma lipsiense liquid quality 0.5%, at 28 ~ 35 DEG C, enzyme is added in liquid 2 ~ 3h is solved, enzymolysis liquid is obtained;
(2)In 28 ~ 35 DEG C, enzymolysis liquid is taken to be seeded to seed culture medium by 10% inoculum concentration, shaking table shaken cultivation 4 ~ 6 days obtains just Culture solution takes first culture solution to be seeded to fermentation medium by 10% inoculum concentration, cultivates 5 ~ 7 days, obtain zymotic fluid, zymotic fluid is taken to centrifuge, It takes supernatant to be evaporated under reduced pressure to the 25 ~ 40% of original volume, obtains fermented concentrate;
(3)In mass ratio 1:5 ~ 8 take Escherichia coli DnaJ protein liquids, acetic acid solution mixing, stand, diluted protein solution are obtained, by matter Measure ratio 2:1 takes diluted protein solution to be uniformly mixed with fermented concentrate to get compound enzyme inhibitor.
The auxiliary agent:In mass ratio 4:1 ~ 2, extracting corn starch, peanut oil mixing are to get auxiliary agent.
The step(2)In seed culture medium:According to the mass fraction, take 20 ~ 30 parts of wheat bran, 6 ~ 15 parts of glucose, 8 ~ 16 parts of yeast extracts, 1000 parts of water, the 15 ~ 20min that sterilizes in 121 DEG C is to get fermentation medium.
The step(2)In fermentation medium:According to the mass fraction, 20 ~ 30 portions of potatos, 6 ~ 15 parts of fructose, 3 ~ 8 are taken Part NaNO3, 4 ~ 8 parts(NH4)2SO4, 0.4 ~ 0.9 part of vitamin B1, 1000 parts of water mixing, sterilize in 121 DEG C 15 ~ 20min to get Fermentation medium.
Compared with other methods, advantageous effects are the present invention:
The present invention is using ganoderma lipsiense as raw material, and through operations such as crushing, enzymolysis, fermented and cultureds, being made, there is β-carbonic anhydrase to inhibit Active extract can effectively inhibit the enzymatic activity, and β-carbonic anhydrase is a kind of metalloenzyme, to pathogenic bacteria and parasite Class metabolism is essential, is catalyzed CO2Aquation, participate in many physiology and pathologic process, including breathing, pH and CO2Stable state, But without this enzyme in vertebrate and chordate animal body, therefore there can be extensive killing effect to pet endoparasite, and On pet without influence, coordinate zinc fingers possessed by the heat shock protein in Escherichia coli DnaJ protein liquids, it can be with β-carbonic acid Acid anhydride enzyme competitive binding Zn2+Achieve the effect that Reverse transcriptase, improve the killing effect to parasite, coordinates and contain in shrubby sophora extract A variety of alkaloids such as some matrines, oxymatrine, Sophoridine can cause polypide food refusal by the nervous system of destruction polypide Effect, plays expelling parasite insecticidal effect, reaches notable expelling parasite insecticidal effect, and be not likely to produce drug resistance.
Specific implementation mode
Auxiliary agent:In mass ratio 4:1 ~ 2, extracting corn starch, peanut oil mixing are to get auxiliary agent.
Seed culture medium:According to the mass fraction, 20 ~ 30 parts of wheat bran, 6 ~ 15 parts of glucose, 8 ~ 16 parts of yeast extracts, 1000 are taken Part water, the 15 ~ 20min that sterilize in 121 DEG C are to get fermentation medium.
Fermentation medium:According to the mass fraction, 20 ~ 30 portions of potatos, 6 ~ 15 parts of fructose, 3 ~ 8 parts of NaNO are taken3, 4 ~ 8 parts (NH4)2SO4, 0.4 ~ 0.9 part of vitamin B1, 1000 parts of water mixing, the 15 ~ 20min that sterilize in 121 DEG C are to get fermentation medium.
The preparation method of shrubby sophora extract:Sophora flavescens cleaning is taken, in 60 ~ 75 DEG C of oven dryings, 80 mesh sieve is crushed, takes sieving Particle in mass ratio 1:4 ~ 6, which are added methanol, impregnates 2 ~ 3h, 40 ~ 60min of ultrasonic wave extraction, mistake under 50 ~ 60 DEG C, 300W power Filter, takes filter residue, rotary evaporation to be concentrated under reduced pressure into the 20 ~ 30% of original volume, obtain concentrate, takes concentrate in mass ratio 1:3 ~ 4 add Enter the acetic acid solution that mass fraction is 10% to mix, stir, filtering takes filtrate, is concentrated under reduced pressure, obtains medicinal extract, is done at 60 ~ 75 DEG C It is dry to water content 5% hereinafter, shrubby sophora extract.
The preparation method of compound enzyme inhibitor, includes the following steps:
(1)It takes ganoderma lipsiense to clean, dry, pulverize 60 mesh sieve in 60 ~ 75 DEG C of drying boxes, and took sieving particle in mass ratio 1:2~ 3 are added water, obtain ganoderma lipsiense liquid, and 0.3% cellulose of pectase and ganoderma lipsiense liquid quality of ganoderma lipsiense liquid quality 0.5% is added Enzyme digests 2 ~ 3h, obtains enzymolysis liquid at 28 ~ 35 DEG C;
(2)In 28 ~ 35 DEG C, enzymolysis liquid is taken to be seeded to seed culture medium by 10% inoculum concentration, is vibrated with 160 ~ 230r/min shaking tables Culture 4 ~ 6 days obtains just culture solution, takes first culture solution to be seeded to fermentation medium by 10% inoculum concentration, cultivates 5 ~ 7 days, must ferment Liquid is taken zymotic fluid to be centrifuged 10 ~ 15 minutes with 4000 ~ 5000r/min, takes supernatant to be evaporated under reduced pressure to the 25 ~ 40% of original volume, obtain Fermented concentrate;
(3)In mass ratio 1:5 ~ 8 take Escherichia coli DnaJ protein liquids, the acetic acid solution that mass fraction is 8% mixes, 15 ~ 20 DEG C of perseverances Temperature stands 30 ~ 50min, obtains diluted protein solution, in mass ratio 2:1 take diluted protein solution to be uniformly mixed with fermented concentrate to get Compound enzyme inhibitor.
A kind of preparation method of pet anti parasitic compound preparation, includes the following steps:
(1)According to the mass fraction, take 30 ~ 50 parts of compound enzyme inhibitors, 20 ~ 30 parts of shrubby sophora extracts, 6 ~ 15 parts of essence, 4 ~ 10 parts Sucrose, 5 ~ 10 parts of auxiliary agents, 20 ~ 40 parts of water;
(2)In 40 ~ 65 DEG C of water-bath, shrubby sophora extract, essence, auxiliary agent, water are taken, is mixed in container, is stirred with 250 ~ 300r/min 30 ~ 50min is cooled to 20 ~ 25 DEG C, and complex enzyme inhibitor mixed is added, and ultrasonic wave disperses 10 ~ 15min to get the anti-parasitism of pet Worm compound preparation.
Auxiliary agent:In mass ratio 4:1, extracting corn starch, peanut oil mixing are to get auxiliary agent.
Seed culture medium:According to the mass fraction, 20 parts of wheat bran, 6 parts of glucose, 8 parts of yeast extracts, 1000 parts of water are taken, in 121 DEG C sterilizing 15min to get fermentation medium.
Fermentation medium:According to the mass fraction, 20 portions of potatos, 6 parts of fructose, 3 parts of NaNO are taken3, 4 parts(NH4)2SO4、0.4 Part vitamin B1, 1000 parts of water mixing, the 15min that sterilize in 121 DEG C are to get fermentation medium.
The preparation method of shrubby sophora extract:Sophora flavescens cleaning is taken, in 60 DEG C of oven dryings, 80 mesh sieve is crushed, takes sieving Grain in mass ratio 1:4, which are added methanol, impregnates 2h, the ultrasonic wave extraction 40min under 50 DEG C, 300W power, and filtering takes filter residue, rotates Evaporation, is concentrated under reduced pressure into the 20% of original volume, obtains concentrate, take concentrate in mass ratio 1:3 are added the second that mass fraction is 10% Acid solution mixing, is stirred, and filtering takes filtrate, is concentrated under reduced pressure, obtains medicinal extract, is dried at 60 DEG C to water content 5% hereinafter, obtaining bitter Conopsea extraction.
The preparation method of compound enzyme inhibitor, includes the following steps:
(1)It takes ganoderma lipsiense to clean, dry, pulverize 60 mesh sieve in 60 DEG C of drying boxes, and took sieving particle in mass ratio 1:2 are added Water obtains ganoderma lipsiense liquid, and 0.3% cellulase of pectase and ganoderma lipsiense liquid quality of ganoderma lipsiense liquid quality 0.5% is added, in At 28 DEG C, 2h is digested, enzymolysis liquid is obtained;
(2)In 28 DEG C, enzymolysis liquid is taken to be seeded to seed culture medium by 10% inoculum concentration, with 160r/min shaking tables shaken cultivation 4 It, obtains just culture solution, takes first culture solution to be seeded to fermentation medium by 10% inoculum concentration, cultivates 5 days, obtain zymotic fluid, take zymotic fluid It is centrifuged 10 minutes with 4000r/min, takes supernatant to be evaporated under reduced pressure to the 25% of original volume, obtain fermented concentrate;
(3)In mass ratio 1:5 take Escherichia coli DnaJ protein liquids, the acetic acid solution that mass fraction is 8% mixes, and 15 DEG C of constant temperature are quiet 30min is set, diluted protein solution, in mass ratio 2 are obtained:1 takes diluted protein solution to be uniformly mixed with fermented concentrate presses down to get complex enzyme Preparation.
A kind of preparation method of pet anti parasitic compound preparation, includes the following steps:
(1)According to the mass fraction, take 30 parts of compound enzyme inhibitors, 20 parts of shrubby sophora extracts, 6 parts of essence, 4 portions of sucrose, 5 parts help Agent, 20 parts of water;
(2)In 40 DEG C of water-bath, shrubby sophora extract, essence, auxiliary agent, water are taken, is mixed in container, 30min, drop are stirred with 250r/min Complex enzyme inhibitor mixed is added to 20 DEG C in temperature, and ultrasonic wave disperses 10min to get pet anti parasitic compound preparation.
Auxiliary agent:In mass ratio 4:1.5, extracting corn starch, peanut oil mixing are to get auxiliary agent.
Seed culture medium:According to the mass fraction, 25 parts of wheat bran, 10 parts of glucose, 12 parts of yeast extracts, 1000 parts of water are taken, in 121 DEG C of sterilizing 18min are to get fermentation medium.
Fermentation medium:According to the mass fraction, 25 portions of potatos, 10 parts of fructose, 5 parts of NaNO are taken3, 6 parts(NH4)2SO4、 0.6 part of vitamin B1, 1000 parts of water mixing, the 18min that sterilize in 121 DEG C are to get fermentation medium.
The preparation method of shrubby sophora extract:Sophora flavescens cleaning is taken, in 68 DEG C of oven dryings, 80 mesh sieve is crushed, takes sieving Grain in mass ratio 1:5, which are added methanol, impregnates 2.5h, the ultrasonic wave extraction 50min under 55 DEG C, 300W power, and filtering takes filter residue, revolves Turn evaporation, is concentrated under reduced pressure into the 25% of original volume, obtains concentrate, take concentrate in mass ratio 1:3.5 addition mass fractions are 10% Acetic acid solution mixing, stir, filtering, take filtrate, be concentrated under reduced pressure, obtain medicinal extract, at 68 DEG C dry to water content 5% hereinafter, Obtain shrubby sophora extract.
The preparation method of compound enzyme inhibitor, includes the following steps:
(1)It takes ganoderma lipsiense to clean, dry, pulverize 60 mesh sieve in 68 DEG C of drying boxes, and took sieving particle in mass ratio 1:2.5 plus Enter water, obtain ganoderma lipsiense liquid, 0.3% cellulase of pectase and ganoderma lipsiense liquid quality of ganoderma lipsiense liquid quality 0.5% is added, At 32 DEG C, 2.5h is digested, enzymolysis liquid is obtained;
(2)In 32 DEG C, enzymolysis liquid is taken to be seeded to seed culture medium by 10% inoculum concentration, with 200r/min shaking tables shaken cultivation 5 It, obtains just culture solution, takes first culture solution to be seeded to fermentation medium by 10% inoculum concentration, cultivates 6 days, obtain zymotic fluid, take zymotic fluid It is centrifuged 13 minutes with 4500r/min, takes supernatant to be evaporated under reduced pressure to the 32% of original volume, obtain fermented concentrate;
(3)In mass ratio 1:7 take Escherichia coli DnaJ protein liquids, the acetic acid solution that mass fraction is 8% mixes, and 18 DEG C of constant temperature are quiet 40min is set, diluted protein solution, in mass ratio 2 are obtained:1 takes diluted protein solution to be uniformly mixed with fermented concentrate presses down to get complex enzyme Preparation.
A kind of preparation method of pet anti parasitic compound preparation, includes the following steps:
(1)According to the mass fraction, take 40 parts of compound enzyme inhibitors, 25 parts of shrubby sophora extracts, 10 parts of essence, 7 portions of sucrose, 8 parts help Agent, 30 parts of water;
(2)In 55 DEG C of water-bath, shrubby sophora extract, essence, auxiliary agent, water are taken, is mixed in container, 40min, drop are stirred with 280r/min Complex enzyme inhibitor mixed is added to 23 DEG C in temperature, and ultrasonic wave disperses 13min to get pet anti parasitic compound preparation.
Auxiliary agent:In mass ratio 4:2, extracting corn starch, peanut oil mixing are to get auxiliary agent.
Seed culture medium:According to the mass fraction, 30 parts of wheat bran, 15 parts of glucose, 16 parts of yeast extracts, 1000 parts of water are taken, in 121 DEG C of sterilizing 20min are to get fermentation medium.
Fermentation medium:According to the mass fraction, 30 portions of potatos, 15 parts of fructose, 8 parts of NaNO are taken3, 8 parts(NH4)2SO4、 0.9 part of vitamin B1, 1000 parts of water mixing, the 20min that sterilize in 121 DEG C are to get fermentation medium.
The preparation method of shrubby sophora extract:Sophora flavescens cleaning is taken, in 75 DEG C of oven dryings, 80 mesh sieve is crushed, takes sieving Grain in mass ratio 1:6, which are added methanol, impregnates 3h, the ultrasonic wave extraction 60min under 60 DEG C, 300W power, and filtering takes filter residue, rotates Evaporation, is concentrated under reduced pressure into the 30% of original volume, obtains concentrate, take concentrate in mass ratio 1:4 are added the second that mass fraction is 10% Acid solution mixing, is stirred, and filtering takes filtrate, is concentrated under reduced pressure, obtains medicinal extract, is dried at 75 DEG C to water content 5% hereinafter, obtaining bitter Conopsea extraction.
The preparation method of compound enzyme inhibitor, includes the following steps:
(1)It takes ganoderma lipsiense to clean, dry, pulverize 60 mesh sieve in 75 DEG C of drying boxes, and took sieving particle in mass ratio 1:3 are added Water obtains ganoderma lipsiense liquid, and 0.3% cellulase of pectase and ganoderma lipsiense liquid quality of ganoderma lipsiense liquid quality 0.5% is added, in At 35 DEG C, 3h is digested, enzymolysis liquid is obtained;
(2)In 35 DEG C, enzymolysis liquid is taken to be seeded to seed culture medium by 10% inoculum concentration, with 230r/min shaking tables shaken cultivation 6 It, obtains just culture solution, takes first culture solution to be seeded to fermentation medium by 10% inoculum concentration, cultivates 7 days, obtain zymotic fluid, take zymotic fluid It is centrifuged 15 minutes with 5000r/min, takes supernatant to be evaporated under reduced pressure to the 40% of original volume, obtain fermented concentrate;
(3)In mass ratio 1:8 take Escherichia coli DnaJ protein liquids, the acetic acid solution that mass fraction is 8% mixes, and 20 DEG C of constant temperature are quiet 50min is set, diluted protein solution, in mass ratio 2 are obtained:1 takes diluted protein solution to be uniformly mixed with fermented concentrate presses down to get complex enzyme Preparation.
A kind of preparation method of pet anti parasitic compound preparation, includes the following steps:
(1)According to the mass fraction, take 50 parts of compound enzyme inhibitors, 30 parts of shrubby sophora extracts, 15 parts of essence, 10 portions of sucrose, 10 parts Auxiliary agent, 40 parts of water;
(2)In 65 DEG C of water-bath, shrubby sophora extract, essence, auxiliary agent, water are taken, is mixed in container, 50min, drop are stirred with 300r/min Complex enzyme inhibitor mixed is added to 25 DEG C in temperature, and ultrasonic wave disperses 15min to get pet anti parasitic compound preparation.
Comparative example 1:It is essentially identical with the preparation method of embodiment 3, it has only the difference is that lacking shrubby sophora extract.
Comparative example 2:It is essentially identical with the preparation method of embodiment 3, it has only the difference is that lacking compound enzyme inhibitor.
Comparative example 3:The anti parasitic compound preparation of Yibin City company production.
Anti parasitic compound preparation prepared by embodiment 1,2,3 and comparative example 1,2,3,4 is respectively to suffering from liver rot, mite The pet dog of worm is tested.Its test result is recorded in table 1.
Table 1:
Test event Embodiment 1 Embodiment 2 Embodiment 3 Comparative example 1 Comparative example 2 Comparative example 3
Kill shortest time/day of liver fluke 17 15 13 30 28 25
The shortest time of mite killing/day 0.6 1 0.8 7 6 9
Control effect/% 97 95 98 72 69 80
In conclusion as shown in Table 1, anti parasitic compound preparation of the invention is to dynamic product structure comparatively perfect, and to parasite Control effect it is preferable, have preferable development prospect.

Claims (4)

1. a kind of pet anti parasitic compound preparation includes following component according to the mass fraction:6 ~ 15 parts of essence, 4 ~ 10 parts of sucrose, 5 ~ 10 parts of auxiliary agents, 20 ~ 40 parts of water, which is characterized in that further include 20 ~ 30 parts of shrubby sophora extracts, 30 ~ 50 parts of compound enzyme inhibitors;
The preparation method of the shrubby sophora extract:It takes kuh-seng to dry, pulverize sieving, takes sieving particle in mass ratio 1:4 ~ 6 are added Methanol impregnates 2 ~ 3h, and in 50 ~ 60 DEG C of ultrasonic wave extractions, filtering takes filtrate, rotary evaporation, be concentrated under reduced pressure into original volume 20 ~ 30%, concentrate is obtained, concentrate in mass ratio 1 is taken:3 ~ 4 are added acetic acid solution mixing, stir, and filtering takes filtrate, is concentrated under reduced pressure, Medicinal extract is obtained, it is dry, obtain shrubby sophora extract;
The preparation method of the compound enzyme inhibitor, includes the following steps:
(1)Ganoderma lipsiense cleaning, drying are taken, are pulverized and sieved, sieving particle in mass ratio 1 is taken:2 ~ 3 are added water, obtain ganoderma lipsiense 0.3% cellulase of pectase and ganoderma lipsiense liquid quality of ganoderma lipsiense liquid quality 0.5%, at 28 ~ 35 DEG C, enzyme is added in liquid 2 ~ 3h is solved, enzymolysis liquid is obtained;
(2)In 28 ~ 35 DEG C, enzymolysis liquid is taken to be seeded to seed culture medium by 10% inoculum concentration, shaking table shaken cultivation 4 ~ 6 days obtains just Culture solution takes first culture solution to be seeded to fermentation medium by 10% inoculum concentration, cultivates 5 ~ 7 days, obtain zymotic fluid, zymotic fluid is taken to centrifuge, It takes supernatant to be evaporated under reduced pressure to the 25 ~ 40% of original volume, obtains fermented concentrate;
(3)In mass ratio 1:5 ~ 8 take Escherichia coli DnaJ protein liquids, acetic acid solution mixing, stand, diluted protein solution are obtained, by matter Measure ratio 2:1 takes diluted protein solution to be uniformly mixed with fermented concentrate to get compound enzyme inhibitor.
2. pet anti parasitic compound preparation according to claim 1, which is characterized in that the auxiliary agent:In mass ratio 4:1 ~ 2, Extracting corn starch, peanut oil mixing are to get auxiliary agent.
3. pet anti parasitic compound preparation according to claim 1, which is characterized in that the step(2)In seed culture Base:According to the mass fraction, 20 ~ 30 parts of wheat bran, 6 ~ 15 parts of glucose, 8 ~ 16 parts of yeast extracts, 1000 parts of water are taken, in 121 DEG C of sterilizings 15 ~ 20min is to get fermentation medium.
4. pet anti parasitic compound preparation according to claim 1, which is characterized in that the step(2)In fermented and cultured Base:According to the mass fraction, 20 ~ 30 portions of potatos, 6 ~ 15 parts of fructose, 3 ~ 8 parts of NaNO are taken3, 4 ~ 8 parts(NH4)2SO4, 0.4 ~ 0.9 part Vitamin B1, 1000 parts of water mixing, the 15 ~ 20min that sterilize in 121 DEG C are to get fermentation medium.
CN201810568158.7A 2018-06-05 2018-06-05 A kind of pet anti parasitic compound preparation Withdrawn CN108403756A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810568158.7A CN108403756A (en) 2018-06-05 2018-06-05 A kind of pet anti parasitic compound preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810568158.7A CN108403756A (en) 2018-06-05 2018-06-05 A kind of pet anti parasitic compound preparation

Publications (1)

Publication Number Publication Date
CN108403756A true CN108403756A (en) 2018-08-17

Family

ID=63141313

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810568158.7A Withdrawn CN108403756A (en) 2018-06-05 2018-06-05 A kind of pet anti parasitic compound preparation

Country Status (1)

Country Link
CN (1) CN108403756A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101015598A (en) * 2007-02-14 2007-08-15 王东辉 Externally used pharmaceutical preparation for treating disease caused by acarids
CN101389764A (en) * 2005-08-01 2009-03-18 Abr有限公司 Carbohydrate compositions from basidiomycete fungi as biocidal agents active against pathogens
CN102028644A (en) * 2009-09-30 2011-04-27 湖北汇特生物医药技术有限公司 Bathing article based on medicinal property of related extraction parts of mugwort
CN104069217A (en) * 2014-07-18 2014-10-01 青岛科维源环保技术有限公司 Mongolian medicine for pet dog anti-parasitism and preparation method of anaesthetic preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101389764A (en) * 2005-08-01 2009-03-18 Abr有限公司 Carbohydrate compositions from basidiomycete fungi as biocidal agents active against pathogens
CN101015598A (en) * 2007-02-14 2007-08-15 王东辉 Externally used pharmaceutical preparation for treating disease caused by acarids
CN102028644A (en) * 2009-09-30 2011-04-27 湖北汇特生物医药技术有限公司 Bathing article based on medicinal property of related extraction parts of mugwort
CN104069217A (en) * 2014-07-18 2014-10-01 青岛科维源环保技术有限公司 Mongolian medicine for pet dog anti-parasitism and preparation method of anaesthetic preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
苏利波,等。: ""苦参抗寄生虫的研究进展"", 《中国病原生物学杂志》 *

Similar Documents

Publication Publication Date Title
CN1831107A (en) Traditional Chinese medicine solid type mixed culture fermentation tech. and its application
CN104172411B (en) A kind of preparation method of black-rice health-care beverage
CN105559089A (en) Liver-protecting and toxin-expelling fruit and vegetable enzyme and preparation method thereof
CN107568415A (en) A kind of livestock and poultry biological fermentation feed
CN106993807A (en) A kind of preparation method of ginger ferment
CN103417752B (en) A kind of liver protection natural product and preparation method thereof
CN101407754A (en) Production process of black fungus rough rice vinegar
CN103301321B (en) Thrombolytic active polysaccharide mixture preparation technology
CN103315359B (en) Grifola frondosus solid state fermentation functional beverage and its preparation method
CN103462168B (en) A kind of preparation method of gingko fresh extract
CN104783290A (en) Preparation method of balsamic enzyme with alcohol-alleviating function
CN105919113A (en) Method for preparing lucid ganoderma and soybean enzyme through microbial fermentation
CN105962375A (en) Hericium erinaceus active lactobacillus preparation and preparation method thereof
CN105368695A (en) Fermented vinegar with poria cocos and propolis and method for manufacturing fermented vinegar
CN108403756A (en) A kind of pet anti parasitic compound preparation
CN110959858A (en) Guiling jelly containing balsam pear juice and preparation method thereof
CN104116116B (en) A kind of preparation method of milled glutinous broomcorn millet vinegar health drink
CN104800298B (en) It is a kind of to be used to treat Chinese medicinal granular formulation of gout and preparation method thereof
CN110339234A (en) It is a kind of for treating the composition and preparation method thereof containing cannabidiol of nervous tinnitus
CN108066392A (en) A kind of probiotics for playing Chinese medicine and beneficial bacterium double effects
CN104585305A (en) Cynanchum atratum extract as well as preparation method and application thereof
CN102641497B (en) Medicinal composition for treating gastrointestinal diseases
KR20110060002A (en) Composition for curing hangover
CN105907819A (en) Biological enzymolysis production method for controllable narrow molecular weight functional chitosan oligosaccharide
CN107164144B (en) Preparation method of cordyceps militaris and penis cervi wine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20180817